Apoptosis is a regulated process of programmed cell death in which cells initiate internal signaling pathways that lead to their own elimination. This mechanism is essential for normal development and tissue homeostasis, but it can also be triggered by external stressors such as hypoxia, ionic disturbances, or infection.
Disruption of apoptosis contributes to a wide range of diseases, including tissue atrophy, neurodegenerative disorders, autoimmune conditions, and cancer. In many cancers, apoptotic pathways are suppressed, enabling cells to survive beyond their natural lifespan. This prolonged survival allows the accumulation and propagation of damaged or misfolded proteins during continued cell division.
Key proteins controlling apoptosis are frequently mutated or dysregulated in cancerous cells. Notable examples include the tumor suppressor p53 and anti-apoptotic regulators such as Bcl-2 and XIAP. p53 functions by halting the cell cycle at the G1 checkpoint following DNA damage, promoting either DNA repair or the initiation of apoptosis. Negative regulators like MDM2 and related proteins inhibit p53 activity, while blocking these regulators restores p53 function.
Members of the Bcl family (e.g., Bcl-2, Bcl-xL) act as apoptosis inhibitors by preventing the release of cytochrome C and suppressing caspase activation, both of which are central events in apoptotic signaling. Similarly, inhibitor of apoptosis proteins (IAPs) such as XIAP and survivin promote cell survival by directly binding caspases and blocking their activation.
Aladdin carries a wide variety of Proteins Involved in Apoptosis, including both Bcl and IAP Inhibitors and Apoptosis Activators, see details in the below sheet.
Bcl Inhibitors
Product ID |
Pouduct name |
Purity | Description |
Gossypol Acetic Acid | ≥97% analytical standard ≥98% 10mM in DMSO | Bcl-2, Bcl-xl, sialyl transferase inhibitor. | |
ABT-199 | ≥99% 10mM in DMSO | BH3 mimetic; Bcl-2 inhibitor. | |
ABT-263 (Navitoclax) | ≥98% 10mM in DMSO | BH3 mimetic; Bcl-2 and Bcl-xl inhibitor. | |
ABT-737 | ≥97% 10mM in DMSO | BH3 mimetic; Bcl-2, Bxl-xl, Bcl-w inhibitor. | |
Obatoclax | ≥98% 10mM in DMSO | BH3 mimetic; Bcl-2 and Bcl-xl inhibitor. |
IAP Inhibitors
Product ID | Pouduct name |
Purity
|
Description
| |
LCL-161 | ≥99% 10mM in DMSO | SMAC mimetic; PXR agonist, IAP inhibitor. | ||
TL-32711 | ≥98% 10mM in DMSO | Smac mimetic; IAP inhibitor. | ||
YM-155 | ≥98% 10mM in DMSO | Survivin inhibitor. |
Other Apoptosis Activators
Product ID | Pouduct name |
Purity
| Description |
DMAPT | ≥98% | Water-soluble parthenolide analog; NF-κB inhibitor. | |
JNJ-26854165 | ≥98% 10mM in DMSO | MDM2 inhibitor. | |
NSC-207895 | ≥98% | Benzofuroxan derivative; MDMX inhibitor | |
Nutlin-3 | ≥98% | Imidzoline derivative; MDM2 inhibitor. | |
RITA | ≥98% 10mM in DMSO | p53 activator. |
Aladdin: https://www.aladdinsci.com/
